AMS MED TECHNOLOGY LIMITED

Advanced MedTech Solutions (AMS) MED TECHNOLOGY LIMITED is a dedicated medical‑device innovator that strives to advance the way we care. By developing insight‑driven technologies, AMS delivers a portfolio of specialised products that enable surgeons and interventional cardiologists to achieve more precise, less invasive treatments and ultimately improve outcomes for patients worldwide.

The company’s flagship range includes the ARTISENTIAL articulating laparoscopic instrument, which mimics the surgeon’s wrist for angled access; the ADVALVE biological heart‑valve prosthesis, a cross‑linked bovine‑pericardium valve with a hybrid stent for durability and natural haemodynamics; the ADVAPATCH pulmonary valved conduit, a stent‑less tri‑leaflet design that replicates native valve function; the ADVA ACE everolimus‑eluting coronary stent system for diverse coronary anatomies; and the ADVAPORT optical trocar, offering enhanced visual guidance and minimal tissue trauma. These solutions are deployed across more than 116 countries, forging partnerships that bring cutting‑edge care to every corner of the globe.

AMS places healthcare professionals at the heart of its mission, fostering a diverse, inclusive culture that attracts talent eager to make a tangible difference in patients’ lives.